Related Experiment Video
Updated: Jun 26, 2026

14:53
A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
17.7K
Ultrasensitive THz biosensor for PCR-free cDNA detection based on frequency selective surfaces.
Christian Weisenstein1, Dominik Schaar2, Anna Katharina Wigger1
1Institute of High Frequency and Quantum Electronics HQE, University of Siegen, Germany.
Biomedical Optics Express
|February 4, 2020
Summary
This study presents an ultrasensitive terahertz (THz) biosensor for label-free DNA detection. The novel asymmetric double split ring resonator (aDSRR) biosensor achieves ultra-low detection limits for direct, PCR-free diagnostics.
Area of Science:
- Terahertz (THz) technology
- Biosensing
- Biomolecule detection
Background:
- Terahertz (THz) technologies offer label-free detection of biomolecules.
- Current THz sensors require improved lower detection limits for biomedical diagnosis.
Purpose of the Study:
- To develop an ultrasensitive THz biosensor for direct, label- and PCR-free DNA detection.
- To achieve detection at physiologically relevant concentrations for biomedical applications.
Main Methods:
- Utilizing asymmetric double split ring resonators (aDSRR) for THz sensing.
- Implementing selective functionalization and localized electric field concentration to enhance sensitivity and specificity.
- Demonstrating sensor performance with human tumor marker MIA cDNA samples derived from total RNA without PCR amplification.
Main Results:
- Achieved ultrasensitive detection of DNA using the aDSRR THz biosensor.
- Demonstrated direct, label-free, and PCR-free detection capabilities.
- Presented measurements of DNA samples with concentrations as low as 1.55 × 10-12 mol/l.
Conclusions:
- The developed aDSRR THz biosensor shows significant potential for ultrasensitive, direct DNA detection.
- This technology advances the application of THz sensors in biomedical diagnostics by lowering detection limits.
- The sensor enables label-free and PCR-free analysis of clinically relevant biomolecules.

